ChainGen Bio is developing a comprehensive toolbox that includes proprietary TfR binding modules and innovative conjugation technologies, enabling the transport of various therapeutic cargoes across the blood-brain barrier and to muscle tissues. This versatile toolbox is being expanded and applied to multiple targets and modalities, resulting in the creation of a BBB-crossing bispecific Aβ-TfR antibody and MSTN/ACVR2 targeting antibody-oligo conjugates, each holding best-in-class potential.
Company Details
Chaingen Bio Questions
Chaingen Bio's LinkedIn profile is https://cn.linkedin.com/company/chaingenbio
Chaingen Bio has
3 employees.
View email and phone details for 3
employees at Chaingen Bio.
Chaingen Bio's industry is
Biotechnology
Chaingen Bio's top competitors are
Makeitskin,
Biocombo Therapeutics,
杭州剂泰医药,
Bebetter Med,
Vacino Biotech,
Informa Connect,
Sineugene Therapeutics,
Singularity.ai,
Genomicare Biotechnology,
Frontera Therapeutics.
Chaingen Bio's categories are Biotechnology
Chaingen Bio's founding year is 2022
